A federal grand jury charged Swapnadip Roy and Vicky Ramancha with conspiracy and smuggling for an alleged counterfeit prescription drug distribution scheme involving Ozempic.
Why it matters. Regulatory authorities are taking action against counterfeiters, potentially impacting the pharmaceutical industry and patient safety.
A federal grand jury in the Middle District of Florida charged two individuals, Swapnadip Roy, 33, and Vicky Ramancha, 37, both Indian nationals, with conspiracy and smuggling related to an alleged transnational counterfeit prescription drug distribution scheme.
A federal grand jury in the Middle District of Florida charged two individuals, Swapnadip Roy, 33, and Vicky Ramancha, 37, both Indian nationals, with conspiracy and smuggling related to an alleged transnational counterfeit prescription drug distribution scheme. The indictment alleges that Roy, Ramancha, and their co-conspirators sold counterfeit Ozempic to distributors in the United States at de…
Roy and Ramancha are charged with one count of conspiracy to commit smuggling and to defraud the United States, three counts of smuggling, and two counts of selling counterfeit drugs and holding counterfeit drugs for sale.
